X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (154) 154
index medicus (105) 105
humans (96) 96
male (62) 62
cancer (54) 54
middle aged (52) 52
female (48) 48
carcinoma, renal cell - drug therapy (46) 46
sunitinib (46) 46
kidney neoplasms - drug therapy (45) 45
aged (42) 42
kidney neoplasms - pathology (38) 38
metastasis (38) 38
renal cell carcinoma (35) 35
urology & nephrology (35) 35
survival (34) 34
carcinoma, renal cell (33) 33
adult (31) 31
care and treatment (30) 30
interferon-alpha (28) 28
sorafenib (28) 28
treatment outcome (28) 28
antineoplastic agents - therapeutic use (27) 27
carcinoma, renal cell - pathology (24) 24
disease-free survival (24) 24
everolimus (24) 24
hematology, oncology and palliative medicine (24) 24
urology (24) 24
neoplasm metastasis (23) 23
targeted therapy (23) 23
prognosis (21) 21
carcinoma, renal cell - secondary (20) 20
chemotherapy (20) 20
analysis (19) 19
tumors (19) 19
aged, 80 and over (18) 18
kidney cancer (17) 17
life sciences (17) 17
retrospective studies (17) 17
vascular endothelial growth factor (17) 17
therapy (16) 16
trial (16) 16
prostate cancer (15) 15
clinical trials (14) 14
molecular targeted therapy (14) 14
antineoplastic agents (13) 13
open-label (13) 13
patients (13) 13
animals (12) 12
antimitotic agents (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
carcinoma (12) 12
clear cell-type renal cell carcinoma (12) 12
diagnosis (12) 12
immunotherapy (12) 12
kaplan-meier estimate (12) 12
medical research (12) 12
metastases (12) 12
metastatic renal cell carcinoma (12) 12
nivolumab (12) 12
young adult (12) 12
article (11) 11
axitinib (11) 11
bevacizumab (11) 11
efficacy (11) 11
health aspects (11) 11
kidney neoplasms - genetics (11) 11
kidney neoplasms - metabolism (11) 11
protein kinase inhibitors - therapeutic use (11) 11
survival rate (11) 11
carcinoma, renal cell - genetics (10) 10
carcinoma, renal cell - metabolism (10) 10
double-blind (10) 10
pazopanib (10) 10
risk factors (10) 10
safety (10) 10
time factors (10) 10
urology and nephrology (10) 10
antineoplastic agents - adverse effects (9) 9
clinical medicine (9) 9
expression (9) 9
klinisk medicin (9) 9
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
medicine, experimental (9) 9
niacinamide - analogs & derivatives (9) 9
prospective studies (9) 9
receptors, vascular endothelial growth factor - antagonists & inhibitors (9) 9
survival analysis (9) 9
vascular endothelial growth factor a - antagonists & inhibitors (9) 9
abridged index medicus (8) 8
cancer therapies (8) 8
carcinoma, renal cell - surgery (8) 8
management (8) 8
nephrectomy (8) 8
pharmacology & pharmacy (8) 8
prostatic neoplasms, castration-resistant - drug therapy (8) 8
research (8) 8
urologi och njurmedicin (8) 8
angiogenesis (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 91 - 97
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that... 
CELL LUNG-CANCER | MELANOMA | MICROENVIRONMENT | INTESTINAL MICROBIOTA | CYCLOPHOSPHAMIDE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | GENES | RESISTANCE | ANTITUMOR IMMUNITY | NIVOLUMAB | CD4 Antigens - immunology | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Gastrointestinal Microbiome - genetics | Fecal Microbiota Transplantation | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Metagenome - genetics | Neoplasms - therapy | Animals | Receptors, CCR - immunology | Interleukin-12 - immunology | Receptors, CXCR3 - immunology | T-Lymphocytes - immunology | Mice | Gastrointestinal Microbiome - immunology | Verrucomicrobia - genetics | Verrucomicrobia - immunology | Care and treatment | Cell receptors | Microbiota (Symbiotic organisms) | Immunotherapy | Epithelial tumors | Physiological aspects | Health aspects | Methods | Apoptosis | PD-1 protein | Lung | Interleukin | Microbiomes | Transplantation | Lymphocytes T | Anticancer properties | Microbiota | Lymphocytes | Bacteria | Feces | Supplementation | Gnotobiotics | Kidneys | Melanoma | Dietary supplements | Interleukin 12 | Abundance | CXCR3 protein | Patients | CD4 antigen | Immune checkpoint | Antibiotics | Flora | PD-L1 protein | Relative abundance | Antitumor activity | CCR9 protein | Tumors | Kidney transplantation | Cancer | Index Medicus | Life Sciences
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 12/2018, Volume 105, pp. S268 - S279
Treating patients with bone metastases from renal cell carcinoma: Bone metastases (BMs) are common and cause morbidity in cancer patients. One third of... 
Systemic therapy | mRCC | Bone metastases | agents | Bone targetting | Local treatment
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 02/2017, Volume 14, Issue 2, pp. 82 - 84
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 5, pp. 417 - 427
Journal Article
Oncotarget, ISSN 1949-2553, 07/2019, Volume 10, Issue 44, pp. 4511 - 4512
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 1746 - 1746
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2019, Volume 380, Issue 12, pp. 1103 - 1115
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. 4519 - 4519
Conference Proceeding
Journal of Clinical Oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 5, pp. 482 - 487
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 12/2018, Volume 105, pp. S261 - S267
Brain metastases in renal cell carcinoma, an unmet need: Brain metastases from renal cell carcinomas are associated with dismal prognosis and might be present... 
inhibitors | therapies | Immune checkpoint | Renal cell carcinoma | Brain metastases | Radiation therapy | Molecular targeted
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2018, Volume 77, Issue 3, pp. 468 - 470
Table 1 - *Days between initiation of immunotherapy and the diagnosis of connective tissue disease. †History of spondyloarthritis. ‡Occurrence of other IrAEs... 
Autoimmunity | Autoantibodies | Treatment | Sjøgren's Syndrome | Autoimmune Diseases | IMMUNE CHECKPOINT BLOCKADE | RHEUMATOLOGY | Studies | Immunoglobulins | Disease | Collaboration | Immunotherapy | PD-L1 protein | Rheumatic diseases | Arthritis | Family medical history | Patients | Cancer | Index Medicus
Journal Article